BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25143360)

  • 21. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
    Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women.
    Bernstein L; Pike MC; Ross RK; Judd HL; Brown JB; Henderson BE
    J Natl Cancer Inst; 1985 Apr; 74(4):741-5. PubMed ID: 3857369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.
    Lee E; Schumacher F; Lewinger JP; Neuhausen SL; Anton-Culver H; Horn-Ross PL; Henderson KD; Ziogas A; Van Den Berg D; Bernstein L; Ursin G
    Breast Cancer Res; 2011 Apr; 13(2):R37. PubMed ID: 21457551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women.
    Dawood MY; Khan-Dawood FS; Ramos J
    Am J Obstet Gynecol; 1986 Dec; 155(6):1246-51. PubMed ID: 3024488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review and Meta-Analysis of Smoking and Circulating Sex Hormone Levels Among Premenopausal Women.
    Ihenacho U; Sriprasert I; Mack WJ; Hamilton AS; Unger JB; Press MF; Wu AH
    Nicotine Tob Res; 2022 Oct; 24(11):1705-1713. PubMed ID: 35291014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C; Vekemans M
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum prolactin levels are positively associated with mammographic density in postmenopausal women.
    Greendale GA; Huang MH; Ursin G; Ingles S; Stanczyk F; Crandall C; Laughlin GA; Barrett-Connor E; Karlamangla A
    Breast Cancer Res Treat; 2007 Nov; 105(3):337-46. PubMed ID: 17260098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of a first pregnancy on the secretion of prolactin.
    Musey VC; Collins DC; Musey PI; Martino-Saltzman D; Preedy JR
    N Engl J Med; 1987 Jan; 316(5):229-34. PubMed ID: 3099198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study.
    Geczik AM; Falk RT; Xu X; Ansong D; Yarney J; Wiafe-Addai B; Edusei L; Dedey F; Vanderpuye V; Titiloye N; Adjei E; Aitpillah F; Osei-Bonsu E; Oppong J; Biritwum R; Nyarko K; Wiafe S; Awuah B; Clegg-Lamptey JN; Ahearn TU; Figueroa J; Garcia-Closas M; Brinton LA; Trabert B
    Breast Cancer Res; 2022 Jan; 24(1):9. PubMed ID: 35081987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women.
    Bauer SR; Fortner RT; Gates MA; Eliassen AH; Hankinson SE; Tworoger SS
    Cancer Causes Control; 2013 Jun; 24(6):1087-97. PubMed ID: 23515936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary Patterns and Plasma Sex Hormones, Prolactin, and Sex Hormone-Binding Globulin in Premenopausal Women.
    Hirko KA; Spiegelman D; Barnett JB; Cho E; Willett WC; Hankinson SE; Eliassen AH
    Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):791-8. PubMed ID: 26980437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.
    Fought AJ; McGathey C; Scholtens DM; Heinz RE; Lowe R; Feeney YB; Lee O; Kmiecik TE; Wolfman JA; Clevenger CV; Gann PH; Gapstur S; Chatterton RT; Khan SA
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2277-84. PubMed ID: 24049126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
    Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ
    Cancer Causes Control; 2001 Jan; 12(1):47-59. PubMed ID: 11227925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women.
    McTiernan A; Wu L; Barnabei VM; Chen C; Hendrix S; Modugno F; Rohan T; Stanczyk FZ; Wang CY;
    Breast Cancer Res Treat; 2008 Mar; 108(2):217-31. PubMed ID: 18297397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.